Clinical management of community acquired pneumonia in the elderly patient

Data de publicació

2019-11-12T14:32:41Z

2019-11-12T14:32:41Z

2016-10-03

2019-11-12T14:32:41Z

Resum

Introduction: Community acquired pneumonia (CAP) is a major health problem in elderly persons and is associated with high morbidity and mortality. Areas covered: This article reviews the most recent publications relative to CAP in the elderly population, with a focus on epidemiology, prognostic factors, microbial etiology, therapy and prevention. The data discussed in this review were mainly obtained from a non-systematic review using Medline, and references from relevant articles. Expert commentary: CAP can occur at any age, but its incidence and risk of death are linked to increasing age. Age-related changes in the immune system make this population more vulnerable to CAP. Mortality in hospitalized patients with CAP ranges from 10% to 12%. However, in the case of elderly patients, several studies have reported mortality rates of up to 25%. Pneumococcal and influenza vaccination comprise one of the most important preventive approaches for CAP in the elderly.

Tipus de document

Article


Versió acceptada

Llengua

Anglès

Publicat per

Taylor and Francis

Documents relacionats

Versió postprint del document publicat a: https://doi.org/10.1080/17476348.2016.1240037

Expert Review Of Respiratory Medicine, 2016, vol. 10, num. 11, p. 1211-1220

https://doi.org/10.1080/17476348.2016.1240037

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

(c) Taylor and Francis, 2016

Aquest element apareix en la col·lecció o col·leccions següent(s)